[PHARMA] QoQ TTM Result on 31-Mar-2020 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-May-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Mar-2020 [#1]
Profit Trend
QoQ- 1.86%
YoY- -429.08%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 2,725,071 2,806,171 2,898,216 2,854,343 2,820,530 2,701,491 2,572,302 3.90%
PBT 35,793 -189,175 -189,383 -191,228 -191,865 58,549 72,267 -37.26%
Tax -9,524 43,758 43,048 44,548 42,418 -24,693 -23,482 -45.05%
NP 26,269 -145,417 -146,335 -146,680 -149,447 33,856 48,785 -33.68%
-
NP to SH 27,489 -144,778 -145,739 -146,437 -149,219 33,816 48,386 -31.28%
-
Tax Rate 26.61% - - - - 42.17% 32.49% -
Total Cost 2,698,802 2,951,588 3,044,551 3,001,023 2,969,977 2,667,635 2,523,517 4.55%
-
Net Worth 337,298 345,040 357,891 350,047 336,573 516,387 518,564 -24.83%
Dividend
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Div 28,740 26,125 22,204 22,188 22,144 27,347 40,348 -20.15%
Div Payout % 104.55% 0.00% 0.00% 0.00% 0.00% 80.87% 83.39% -
Equity
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Net Worth 337,298 345,040 357,891 350,047 336,573 516,387 518,564 -24.83%
NOSH 261,705 261,705 261,705 261,229 261,229 261,229 261,229 0.12%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 0.96% -5.18% -5.05% -5.14% -5.30% 1.25% 1.90% -
ROE 8.15% -41.96% -40.72% -41.83% -44.33% 6.55% 9.33% -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 1,042.20 1,073.54 1,109.43 1,092.66 1,081.04 1,035.84 987.13 3.66%
EPS 10.51 -55.39 -55.79 -56.06 -57.19 12.97 18.57 -31.46%
DPS 11.00 10.00 8.50 8.50 8.50 10.50 15.50 -20.35%
NAPS 1.29 1.32 1.37 1.34 1.29 1.98 1.99 -24.99%
Adjusted Per Share Value based on latest NOSH - 261,229
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 189.08 194.70 201.09 198.05 195.70 187.44 178.48 3.90%
EPS 1.91 -10.05 -10.11 -10.16 -10.35 2.35 3.36 -31.26%
DPS 1.99 1.81 1.54 1.54 1.54 1.90 2.80 -20.27%
NAPS 0.234 0.2394 0.2483 0.2429 0.2335 0.3583 0.3598 -24.83%
Price Multiplier on Financial Quarter End Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 -
Price 5.00 4.32 2.22 1.26 2.06 2.44 2.84 -
P/RPS 0.48 0.40 0.20 0.12 0.19 0.24 0.29 39.71%
P/EPS 47.56 -7.80 -3.98 -2.25 -3.60 18.82 15.29 112.35%
EY 2.10 -12.82 -25.13 -44.49 -27.76 5.31 6.54 -52.94%
DY 2.20 2.31 3.83 6.75 4.13 4.30 5.46 -45.29%
P/NAPS 3.88 3.27 1.62 0.94 1.60 1.23 1.43 93.94%
Price Multiplier on Announcement Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 17/03/21 19/11/20 19/08/20 19/05/20 20/02/20 20/11/19 23/08/19 -
Price 3.49 5.72 4.42 1.88 2.04 2.21 2.66 -
P/RPS 0.33 0.53 0.40 0.17 0.19 0.21 0.27 14.24%
P/EPS 33.20 -10.33 -7.92 -3.35 -3.57 17.04 14.33 74.64%
EY 3.01 -9.68 -12.62 -29.82 -28.04 5.87 6.98 -42.77%
DY 3.15 1.75 1.92 4.52 4.17 4.75 5.83 -33.53%
P/NAPS 2.71 4.33 3.23 1.40 1.58 1.12 1.34 59.58%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment